The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study

The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study

Objective: We aimed to construct risk stratification to help set individualized treatment strategies and intensities for different subgroups of patients. Methods: The Esophagus Immune Prognostic Index (EIPI) scores were constructed according to the levels of derived neutrophil-to-lymphocyte ratio (d...

Full description

Bibliographic Details
Main Authors: Yilin Yu, Haishan Wu, Jianjian Qiu, Dongmei Ke, Yahua Wu, Mingqiang Lin, Qunhao Zheng, Hongying Zheng, Zhiping Wang, Hui Li, Lingyun Liu, Jiancheng Li, Qiwei Yao
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Translational Oncology
Subjects:
Esophageal squamous cell carcinoma
Definitive chemoradiotherapy
Esophagus immune prognostic index
Risk stratification
Individualized treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322000894

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322000894

Similar Items